Researchers at the University of Texas Medical Branch at Galveston have developed an Ebola vaccine, the first to be tested against the Makona strain that emerged early in 2014 and has killed nearly 10,000 people. Peter J. Hotez, fellow in disease and poverty, comments on its advantages and drawbacks compared to another Ebola vaccine being tested in humans.
Read the full article in the April 8, 2015, Houston Chronicle.
Oct 20 2021 | Foreign Policy
Oct 19 2021 | Foreign Policy